pemvidutide

Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News
BioSpace
Fri, 12/1/23 - 09:46 am
Altimmune
clinical trials
obesity
GLP-1 agonist
pemvidutide
Altimmune completes dosing in MOMENTUM trial to treat obesity
Clinical Trials Arena
Wed, 09/13/23 - 11:15 am
Altimmune
clinical trials
pemvidutide
obesity
Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist
Fierce Biotech
Wed, 09/14/22 - 08:06 pm
Altimmune
NASH
clinical trials
pemvidutide
Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy
Seeking Alpha
Tue, 09/28/21 - 11:14 pm
Altimmune
clinical trials
obesity
pemvidutide